ã³ã³ã¿ã¯ã ãã¬ãª: Phil Hay Global cell (202) 409 2909, phay@worldbank.org Rogers Kayihura (250) 085 111 45, rkayihura@worldbank.org ã¯ã·ã³ãã³: Katya Svirina (202) 458-1042, esvirina@worldbank.org  ãã¬ãªã2007 幎6 æ14 æ¥ âæ¬æ¥ä»ãã§ã«ã¯ã³ãã®éŠéœãã¬ãªã§çºè¡šãããäžçéè¡ã® HIV/ãšã€ãºæ°å ±åæžã«ãããšã瀟äŒçã«åãã€ããèã®æ ¹éåã³ãã¥ããã£ã®åå¡ããã³ã³ããŒã ã®é
åžããã³æåœæ²»çãšçžãŸã£ãŠãã¢ããªã«å€§éžã§æšå¹Žäžã«å€§äººåäŸåãã㊠200 äžãè¶
ãåœã奪ãã2,470 äžäººã«èŽåœççç¶ãšã®æ¥ã
ã®éãã匷ããŠããç«ç
ã®çåšã«å¯Ÿããæžéã®å¹æãåãŒãå§ããŠããã  æ°å ±åâ2000ïœ2006 幎æã¢ããªã«è€æ°åœãšã€ãºã»ããã°ã©ã : éçºå±æ©ã«å¯Ÿããäžçéè¡ã®å¯Ÿå¿ã®ææ(The Africa Multi-Country AIDS Program 2000-2006: Results of the World Bankâs Response to a Development Crisis)  ã«ãããšãHIV/ãšã€ãºæ²æ»
éåã®ç©¶æ¥µçæåŠã¯ã广çäºé²æªçœ®ãä»è·ãæ²»çãšå
±ã«ãã¢ããªã«è«žåœã®ã瀟äŒçå
ç«ã·ã¹ãã ãã®ä¿é²æªçœ®ã®é
åãããã«ããã£ãŠãããå³ã¡ãHIV/ãšã€ãºã«é¢ãã人ã
ã®èããèªèããŸã瀟äŒçããã³å人çè¡åãå€é©ããæçµçã«ã¯ HIV ã®é²è¡ãåŸéããããšã€ãºã«ãã被害ãé»ãããšã®ã§ããããã«ãããšããŠããã  ããã«ããããã®å€é©ãè¡ãããŠãããŠã¬ã³ããã±ãã€ããžã³ãããšã®åœã
ãããšããªãã¢ãã«ã¯ã³ãããã«ã³ãã£ããã©ãŠã£ãã¶ã³ãã¢ååœã®éœåžéšã§ãèå»¶ã®ã¹ããŒãã«æžéã®å
ããèŠããããšå ±åããŠãããããããªãããåã¢ããªã«ã¯ã空åã®ææçã§ãäŸç¶ãšããŠå倧éžã«ãããèå»¶ã®äžå¿ã§ãããæè¿å®æœãããäžåž¯å¥èª¿æ»ã«ãããšãããã¯ãã®ç¬¬Â 2 ã®éœåžã§ãããã©ã³ã·ã¹ã¿ãŠã³ã§ã¯ã30ïœ34 æã®å¥³æ§ããã³ 40ïœ44 æã®ç·æ§ã®å®ã« 70% ã HIV ææè
ã§ãã£ããæ±ã¢ããªã«ã®è«žåœã¯ãã»ãã¯ã¹ç£æ¥ãªãã³ã«äžè¬äœæ°ã®åæ¹ã®å±€ã§ããªãã®æ°èŠææãèŠããããšãã£ãæ··åããæµè¡ã®åœ¢æ
ã«çŽé¢ããŠããã  ããšã€ãºã¯å€çã®ããã«ã¢ããªã«ã«ãã£ãããšå¿ã³èŸŒã¿ãäœå¹ŽãçµéããçŸåšãææçãæžéãå§ããŠãããçã
å€ãã®äººã
ãæ²»çã«ããæãããŠããããã«èŠåããããŠããä»ãªããã®æãããç
æ°ã«å¯ŸãèŠæãæ ããªãããã«ããªããã°ãªããŸãããããšãåWHO äºåå±é·è£äœã§ããã¯ãã®åç倧è£ãæŽä»»(1999ïœ2003 幎)ãçŸäžçéè¡å¯é åãžã§ã€ã»ãããã£ã¯èšã£ãŠãããããã«ç¶ããŠãã2001 幎ïœ2005 幎ã®éã«ãHIV ã«å¯Ÿããäžçã®æ åºé¡ã¯ã幎ã«20 åç±³ãã«æªæºã®ã¬ãã«ãã80 åç±³ãã«ãžãšå®ã«4 å匷ã®äŒžã³ã瀺ããŠãããå
é²8 ã¶åœããã®æ°ããªæŽå©çŽæãšå
±ã«ã倧ãã«æè¿ãããããšã§ã¯ãããŸãããæ®å¿µãªããããã§ããããã®åœã
ãå¿
èŠãšããåã«ã¯ãŸã è¶³ããŸããããŸããäžçã®ããŒããŒããã³éçºéäžåœãHIV/ãšã€ãºæ²æ»
ã®ããã®åã
ã®åªåãããã«åå¡ã§ãããããéçºæŽå©äœå¶ã®çŸç¶ã®ãããããããä¿®æ£ããªããã°ãªããŸãããã  10 åãã«ãè²·ãåŸããã® Â äžçéè¡ã®æ°å ±åã§ã¯ãå
å®ãª HIV/ãšã€ãºæŠç¥ãšè¡åèšç»ãæã€åœã«å¯Ÿãé·æçæ¯æŽãæäŸããã¹ã 2000 幎ã«èšç«ãããã10 åãã«ã®ã¢ããªã«è€æ°åœ HIV/ãšã€ãºã»ããã°ã©ã (MAP) ã®çµæãè©äŸ¡ããŠãããå
šé¡è£å©ãšç¡å©æ¯ããŒã³ã®çµã¿åããã«ãããäžçéè¡ã¯ã6 幎é (2001ïœ2006 äŒèšå¹ŽåºŠ) ã§ã¢ããªã«ã«å¯Ÿã HIV/ãšã€ãºã®ããã« 12 å 8,600 äžç±³ãã«ãäžéã® HIV 察çäžçæè³ã®ã»ãŒ 50% ãæäŸããã  MAP ã®ããã·ã§ã³ã¯ãæ¿åºã¬ãã«ã§ã®èªå©åªåãšçåºéã®å£ãè¶ãã察å¿ã®å¥šå±ãæ¯ããåãžã®ææãäºé²ããããã°ã©ã ã®æ¡åŒµããšã€ãºã«åœ±é¿ãåããåäŸãã¡ã®æŽå©ãåœå¢éã®åé¡ã«åãçµãå°åããã°ã©ã ã®ç«ã¡äžããç¥èã®å
±æçãéç¹é
ç®ãšããŠãHIV äºé²ã»ä»è·ã»æ²»çããã°ã©ã ãžã®ã¢ã¯ã»ã¹ãæ Œæ®µã«åŒãäžãããšãããã®ã§ãã£ãã  ãããžã§ã¯ãè©äŸ¡ããã³ã¢ããªã«ã® MAP 諞åœã® 90% 匷ããã®ãã£ãŒãããã¯æžåŒã®éèšã«ãããšãã¢ããªã«è€æ°åœ HIV/ãšã€ãºã»ããã°ã©ã ã¯ãååœã§äžèšãå«ãå€ãã®ææã®éæãæ¯æŽããã  - æ°ããªææãäºé²ããããã«ã23 ã¶åœã§ 1,546, 388 人ã®å¥³æ§ã«æ¯ããåãžã® HIV ææäºé²ã®ãµãŒãã¹ãæäŸã25 ã¶åœã§ã³ã³ããŒã 1,298,410, 996 åãé
åžã17 ã¶åœã§ 1,512 ã®ã«ãŠã³ã»ãªã³ã°ããã³ãã¹ãæœèšãæ°èšã25 ã¶åœã§ã»ãŒ 700 äžäººã«ãã¹ã宿œã23 ã¶åœã§ 2,258,844 人ã®åŽåè
ã«åè·å Žã«ãã㊠HIV ã«å¯Ÿããåèãšä»è·ã®ããã°ã©ã ãæäŸã
 - ãšã€ãºã®ã€ã³ãã¯ããåãããããã«ãMAP 諞åœã«ããã£ãŠ 50,000 ã®ã³ãã¥ããã£ãåžæ°å£äœãé幎éšãHIV ãšå
±ã«ç掻ãã人ã
ã®çµç¹ãªã©ã®äºé²ã»ä»è·åªåãžã®è³éæŽå©ã21 ã¶åœã§ãšã€ãºã«ãã圱é¿ãåãã 1,779,872 人ã®å€å
ããã®ä»å·ã€ããããåäŸãã¡ã«å¯Ÿããä»è·ãšæŽå©ãæäŸã
 - æ²»çã®æäŸãšããŠã20 ã¶åœã§ 287, 805 äººã®æ¥åèŠæææ£è
ãæ²»çã27 ã¶åœã§ çŸåšæã¬ãããŠã€ã«ã¹ (ART) æ²»çäžã«ãã 554, 648 人äžÂ 26, 699 人㮠ART è¬åè²»çšãè² æ
ã562, 366 人ã®èšç·Žãšå»çå¶åºŠã®åŒ·åããè¿å¹Žã® ART è¬å€äŸ¡æ Œã®äœäžãšããŒããŒã®è³éæŽå©é¡ã®é¡èãªå¢å€§ã«äŒŽã ART ã®åºç¯ãªæ®åãå©ããã
 ããšã€ãºããããŸã§ãŸã£ããçµéšããããšã®ãªããããªéçºã®ç·æ¥äºæ
ã§ããããšããæã
ã«ãšãæçœãšãªã£ãæç¹ã§ã諞åœãè¿
éã§æè»æ§ãããããã€é©æ°çãªãæ°ããªéçºçšäžä¿¡æ ãå¿
èŠãšããã§ãããããšãçè§£ããããã§ã¢ããªã«è€æ°åœãšã€ãºã»ããã°ã©ã ãæŽåããã®ã§ããããš2000 幎ã«ã¢ããªã«å°åã§MAP ã¢ãããŒããä»ã«å
é§ããŠè¡ãªã£ãäžéã®äžçHIV/ãšã€ãºã»ããã°ã©ã ã®ããã¬ã¯ãŒã¯ã»ãºãŒãã£ãŒå±é·ã¯èšãããHIV/ãšã€ãºã«å¯Ÿããäžççè³éæ åºã¯åŸ®ã
ãããã®ã§ãæ¿æ²»çç¡äœçºãäžè¬çããŸãäºå®ãèªããããšããªãé¢šæœ®ãæ·±ãæ ¹ã匵ã£ãŠãããã®2000 幎ã®èŠéãã®æãç¶æ³ãããããã«é ããŸã§ãã£ãŠãããã«æéããŸããMAP ã¯ãé«åºŠãªãªãŒããŒã·ããã«çŠç¹ãçµããåžæ°å£äœã®åŒ·åãªé¢äžãæ¯æŽããããŸã§ã«äŸã®ãªããããªè³ééãšæè¡çåŸæŒããæäŸããããšã§ãåè¿°ã®æ¬ é¥ãæ¯æ£ããããèæ¡ãããŸãããã¢ããªã«è«žåœã«å¯Ÿãçµæãã(ãããç»äžçã§ã¯ãªã) æ¯æŽãæç€ºããããšã§ãMAP ã¯HIV ãã¢ããªã«å€§éžã«å¯Ÿããå
±éã®è
åšã§ããç¹ã匷調ããååœéŠè³ãæ²é»ãç Žãã®ã容æã«ããŸãããã  ãºãŒãã£ãŒå±é·ã®èšãã«ã¯ãMAP ã®ã¢ãããŒãã¯ã驿°çãªå€§èŠæš¡ããã°ã©ã ã䜿çšããŠããããç¶ããŠã2003 幎以éã«äžçåºéãš PEPFAR (倧統é ãšã€ãºææžç·æ¥èšç») ã«ããå©çšå¯èœãšãªã£ãæ°èŠ HIV/ãšã€ãºè³éã®äœååãã«ããååœãå©çšã§ããåºç€ã圢æããããšã§ãç·æ¥äºæ
ã«å¯Ÿãè¿
éã«å¯ŸåŠããããšãå¯èœã§ããããšã瀺ããã MAP ããã°ã©ã ã¯ã«ãªãæµ·å°åºã§çå®ããããã®ã§ãããMAP 颚ã®ã¢ãããŒãã¯äžå€®ã¢ãžã¢ã§è¿œåŸãããŠããããã®ã¹ããŒããšæè»æ§ã«ãããMAP ã¯äžéã®é³¥ã€ã³ãã«ãšã³ã¶ã»ããã°ã©ã ã«ããã¢ãã«ãšããŠå©çšãããã  ã³ãã¥ããã£ã®åå¡ Â å°å瀟äŒã«æ ¹ãããã°ã«ãŒãã NGO ã®ç©æ¥µçé¢äžãªãã«ãHIV ã®åºããã黿¢ããç
ã«èŠãã¿æ»ãåŸ
ã€å€§äººã®ä»è·ãå€å
ãšãªã£ãåäŸãã¡ã®äžè©±ãæå裡ã«è¡ãªããåœã¯ååšããªãäºå®ã«çæããäžçéè¡ã®ã¢ããªã« MAP ã§ã¯ã5 å 200 äžç±³ãã«ããHIV/ãšã€ãºã«é¢ããæ¥èŸ±æã®åæžãå±éºãªè¡åã®ä¿®æ£ãæ£è
ã®ä»è·ã圱é¿ãåãã人ã®äžè©±ãªã©ã®èã®æ ¹æŽ»åãè¡ãªã£ãŠããã5 äžãè¶
ããã³ãã¥ããã£ã»ã°ã«ãŒããNGOããã®ä»ã®çµç¹äœã«åããã  ã³ãã¥ããã£ã»ã¬ãã«ã«å¯Ÿãæå
¥ããã 5 åãã«ãè¶
ããéé¡ã®ã°ã«ãŒãã«ãã䜿çšå
èš³ã¯ã56% ãäºé²æŽ»åã«ã15% ãä»è·ãšæ²»çã«ã11% ãå€å
ã®äžè©±ãæªäº¡äººããšã€ãºæ£è
女æ§ãžã®ç¡æ
ä¿å°é¡èè³ã«ã18% ãããŒã«ã«ã»ã¬ãã«ã§ä»è·ã𿝿Žäœæ¥ãæäŸããå°èŠæš¡ NGO ã®èšç·Žãšæå°ã«ããããã䜿çšãããã  ãšã€ãºãèºçããã©ãªã¢å¯Ÿçäžçåºéã®ããã·ã§ã«ã»ã«ã¶ããã³äºåå±é·ã«ãããšãNGOããã®ä»ã®ã³ãã¥ããã£ã»ã°ã«ãŒãã®ãšã€ãºå¯Ÿçäœæ¥ã«è³éæŽå©ããããšãã MAP ã®ã¢ãããŒãã¯ãäžçåºéãä»ã®äž»èŠéçºæŽå©æ©é¢ããã®åŸã«ç¶ãéãæ·èšãããã®ã§ãã£ãã  ãMAP ã¯ãHIV/ãšã€ãºã«å¯Ÿããå¯ŸåŠæ³ã®ããŒèŠçŽ ã§ãããšæã
ãä»ã§ã¯ç¥ã£ãŠãããåžæ°å£äœã®æ¯æŽãšããç¹å®ã®ç®æšã®ããã«ãMAP ã¯å
é§ãã§ãã£ããšèšããŸãããã®ãããäžçéè¡ã¯ãHIV/ãšã€ãºãšã®æŠãããè²§å°ã«å¯ŸããæŠããéçºãç®æããéçºã«ãããå¥åº·ã®å¢é²ã®ããã®æŠããšããæ çµã¿ã®äžã§æšé²ã§ãããç¹å¥ã®ç«å Žã«ãããŸããããšã«ã¶ããã³ã¯ç¶ãããããªããšããŠãäžçåºéãäžçéè¡ã®æäŸããŠããããšãè©ä»£ãããããããªç¶æ³ãäºæž¬ããããšã¯ã§ããŸãããä»åŸäžçéè¡ãå»çåéã軜èŠããããHIV/ãšã€ãºã®ããã°ã©ã ã軜èŠãããããªããšãããããã°ã倧ãã«æžå¿µããããšã«ãªãã§ããããã  ä»åŸ5ïœ10 幎ã®äžéãšHIV/ãšã€ãº  ä»åŸ5 幎éããã³ãã®å
ã®ã¢ããªã«ã§ã®HIV/ãšã€ãºæŠç¥ã®æŽæ°ã«ããããäžéã®èŠæ¹ã¯ãHIV/ãšã€ãºããäºæž¬å¯èœãªè¿ãå°æ¥ã«ãã£ãŠã¯ããµãã©ä»¥åã®ã¢ããªã«ã«ãšãéåžžã«å€§ããªçµæžçã瀟äŒçããã€äººçãªèª²é¡ã§ããç¶ãããåå°åã¯äžçã®HIV/ãšã€ãºã®æµè¡ã®äžå¿å°ã§ãããã¢ããªã«ã§ã¯2,500 äžäººãè¶
ãã人ã
ãHIV ã«ææããŠããããšã€ãºã¯å倧éžã§ã®æ©æ»ã®åå ã®ããããšãªã£ãŠãããHIV/ãšã€ãºã¯è¥å¹Žå±€ããã³å¥³æ§å±€ã«åã£ãŠäœçšããŠãããè¥ã女æ§ãææããå¯èœæ§ã¯ãè¥ãç·æ§ã«æ¯ã¹3 åãé«ããåºç¯ãªæµè¡ã«ããã18 ææªæºã§ç芪ãŸãã¯äž¡èŠªã®ããªãåäŸãã¡ã¯ãæšå®1,200äžäººãããåå®¶åºãžã®ããŸãã人çè³æºãæ°ééšéãå
Œ
±éšéãžã®ã€ã³ãã¯ãã¯ãäžéã®å
æ¬çãªäœ¿åœã§ããè²§å°ã®è»œæžã«ã圱é¿ãããèŠããã«HIV/ãšã€ãºã¯ãåå°åã®éçºç®æšããäžçã®ä»ã®ã©ã®å°åãããæ·±å»ã«è
ãããŠããã  æ°å ±åã§ã¯ãåäžã®çæ³çãšã€ãºã»ããã°ã©ã ã¯ååšããªãããšã¯æçœã§ãããšããŠãããåã
ã®åœãã匷åãªçŸå°ã®ããŒã¿ãåºã«ããŸãæåäŸã倱æäŸããæèšãåŸãŠãåã
ã®æµè¡ã®èŠå ãçè§£ããåªå
é äœä»ãã®åœå
ããã°ã©ã ãçå®ããå¿
èŠããããããã«å ±åã¯ãããã»ã¹ãåžžã«ã¹ã ãŒãºã«é²ããããããã§ã¯ãªãããšãæªã ã«æµ®ãæ²ã¿ãããããšã«ãèšåããããããªãããç¶ç¶çåŠç¿ãšæ¹åãéããŠãã¢ããªã«è€æ°åœãšã€ãºã»ããã°ã©ã ããã¢ããªã«å
šåã§äœçŸäžäººãã®ææè
ãããã³åœ±é¿äžã«ãã人ã
ã«ãæŽå©ã®æãããã®ã¹ãåœå
ã®äºé²ãæ²»çãä»è·ãããã³è»œæžãµãŒãã¹ãæ¯æŽããŠããã  ãåœã
ã§ç
æ°ã«å¯Ÿãåªäœãç²åŸãå§ããŠãããšããææ°ãé«ããŠãããäºäŸãèªããããã«ãªããŸããããšã¯èšãããã®ãããªææãå¢ãããŠè¡ãããã«ã¯ãæç¶±ãç·©ããããã«ã¯ãŸãããŸãããããšäžçéè¡ã¢ããªã«ã»ãšã€ãºã»ãã£ã³ããŒã³ã»ããŒã ãACTafrica æ
åœãããŒãžã£ãŒã®ãšãªã¶ãã¹ã»ã«ãŒã«ã¯èšãããä»åŸ5 幎å
ãèŠéããšããéå»ã®çµéšãèšãç¥ããªã貎éãªæããšãªããŸããçŸå°åœã®çºæ³ã§æ¹åä»ãããã察å¿ã¯ãçŸå°ã§ã®æµè¡ç¶æ³ããã³æµè¡ããããèŠå ã®ç¶¿å¯ãªåæã«åºã¥ããã®ã§ããããåºç¯ãªé¢ä¿çµç¹(ããã§ã®é¢ä¿çµç¹ã«ã¯ãåœäºåœèªäœãåœééçºã³ãã¥ããã£ãšæŽå©äŸäžçµç¹ãããŒã«ã«ã»ã³ãã¥ããã£ãNGO ã°ã«ãŒãããšã€ãºãšå
±ã«ç掻ããŠãã人ã
ã®çµç¹ãã¡ãã£ã¢ããã®ä»ããã) ã«ããå¹çãã宿œã«ç§»ãããããããŸããæ³šææ·±ãã¢ãã¿ãŒãã調æŽãããããšãã圢æ
ããHIV/ãšã€ãºã«ã¢ããªã«ã®äººã
ãåå©ããå©ããšãªãå¯äžã®æç¶çãªæ¹æ³ã§ããã Â
|